| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/1992 | EP0474857A1 Method for the protection of plants against pathogens |
| 03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
| 03/18/1992 | EP0474789A1 Cysteine thiol-protected peptides for use in immunoassays |
| 03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
| 03/18/1992 | EP0474764A1 Method to treat rheumatoid arthritis |
| 03/18/1992 | EP0474676A1 Production of ibdv vp2 in highly immunogenic form |
| 03/18/1992 | EP0474646A1 Bordetella vaccines |
| 03/18/1992 | EP0474645A1 Protein complex |
| 03/18/1992 | EP0420894A4 Large scale method for purification of high purity heparinase |
| 03/18/1992 | EP0303625B1 Polypeptide competitor for immunoglobulin e |
| 03/18/1992 | EP0265496B1 Flecainide derivatives and their use in immunoassays |
| 03/18/1992 | EP0216786B1 Purification, production and use of tumor necrosis factors |
| 03/18/1992 | CN1059601A Assay for detecting and/or quantifying mammalian antibody response to epstein-barr virus membrane antigen |
| 03/18/1992 | CN1059471A Heamophilus paragallinarum vaccine |
| 03/18/1992 | CA2091905A1 Fungicidally active compounds |
| 03/18/1992 | CA2091759A1 Method and composition for controlling proliferation of cells |
| 03/18/1992 | CA2051455A1 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/18/1992 | CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/17/1992 | US5097019 Pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4 |
| 03/17/1992 | US5097018 Sequential heat treatment of blood-clotting factor products |
| 03/17/1992 | US5096886 Bacteriostats |
| 03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
| 03/17/1992 | US5096838 Fluorescent tracers for detection of barbiturates and for antiserums |
| 03/17/1992 | US5096825 Gene for human epidermal growth factor and synthesis and expression thereof |
| 03/17/1992 | US5096815 Generation and selection of novel dna-binding proteins and polypeptides |
| 03/17/1992 | US5096705 Used for antitumor or antiviral treatment or for treatment of immunosuppressive conditions |
| 03/17/1992 | US5096696 Cleaving albumin and binding radioactive material to fragment, detecting thrombosis in vascular system using scintigraphic imaging |
| 03/17/1992 | US5096593 Separation material derived from glucomannan for blood coagulation factor, preparation and use thereof |
| 03/17/1992 | CA1297635C Protein purification |
| 03/17/1992 | CA1297634C Anticoagulating substance and preparation process thereof |
| 03/17/1992 | CA1297630C Tangential flow affinity ultrafiltration |
| 03/17/1992 | CA1297437C Process for the preparation of protease inhibitors |
| 03/17/1992 | CA1297436C Eucaryotic expression system |
| 03/17/1992 | CA1297434C Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same |
| 03/15/1992 | WO1992005198A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 03/15/1992 | WO1992005188A1 Production of multimeric glycoproteins through chemical coupling |
| 03/15/1992 | WO1992004908A1 Drug containing cd14 |
| 03/15/1992 | CA2091266A1 Expression of macrophage inducible proteins (mips) in yeast cells |
| 03/15/1992 | CA2072626A1 Drug containing cd14 |
| 03/15/1992 | CA2068651A1 Production of multimeric glycoproteins through chemical coupling |
| 03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
| 03/13/1992 | WO1992004372A1 Active site of interleukin-8: polypeptide analogs and antibodies |
| 03/13/1992 | WO1992004367A1 Separation of proteins and dyes |
| 03/13/1992 | CA2091558A1 Active site of interleukin-8: polypeptide analogs and antibodies |
| 03/13/1992 | CA2047633A1 Inactivation of gene transcription in plants using altered transcriptional activators |
| 03/12/1992 | WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | DE4028622A1 Prepn. of collagen sponges for cosmetic and pharmaceutical use - by alkali treatment to denature surface, acid treatment, washing comminution, freezing and freeze drying |
| 03/12/1992 | DE4028487A1 Interleukin inhibitors of cytokine synthesis - used to treat nerve inflammation, associated pain, spinal injury and slipped disc |
| 03/12/1992 | DE4027675A1 Verfahren zur schnellen synthese von grossen zahlen traegergebundener oder freier peptide Method for the rapid synthesis of large numbers traegergebundener or free peptide |
| 03/12/1992 | CA2091335A1 Antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | CA2051047A1 Glycoprotein sialylation by gene manipulation |
| 03/12/1992 | CA2051044A1 Cytostatic agent |
| 03/12/1992 | CA2049214A1 Use of bacillus thuringiensis microbes for controlling the lesser mealworm, alphitobius diaperinus |
| 03/12/1992 | CA2048094A1 Methods of conjugating actinomycin d |
| 03/11/1992 | WO1992004453A1 Plant parasitic nematode control |
| 03/11/1992 | EP0474601A2 Expression of genes encoding plant pathogenesis related proteins in plant associated bacteria |
| 03/11/1992 | EP0474553A1 Actinonin derivatives |
| 03/11/1992 | EP0474506A1 Antimicrobial peptides |
| 03/11/1992 | EP0474453A2 Pharmaceutical composition comprising an active peptide or protein and a heat-labile enterotoxin B and its mucous use |
| 03/11/1992 | EP0474416A2 Antigenic material, antibodies raised thereto, hybridomas for producing antibodies, and immunoassays incorporating such antibodies |
| 03/11/1992 | EP0474323A1 Reducing chelants, their complexes with technetium and rhenium, method for their preparation and their use in diagnosis and therapy |
| 03/11/1992 | EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations |
| 03/11/1992 | EP0474273A2 A polypeptide capable of interacting with thrombin |
| 03/11/1992 | EP0474213A1 Method for chromatographic purification of insulins |
| 03/11/1992 | EP0474212A2 Enzymatic process for conversion of preproinsulin to insulin |
| 03/11/1992 | EP0474141A1 Peptide or its salts |
| 03/11/1992 | EP0473936A1 Renin Inhibitors |
| 03/11/1992 | EP0473725A1 Composition and method to detect sensitivity to alpha interferon therapy |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 03/11/1992 | EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 03/11/1992 | EP0431042A4 A method of preparing an active human neutrophil chemotactic factor polypeptide |
| 03/11/1992 | EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
| 03/10/1992 | WO1992004382A1 Solubilization of proteins in active forms |
| 03/10/1992 | US5095139 Fungicides |
| 03/10/1992 | US5095097 Diagnostics |
| 03/10/1992 | US5095096 Fused protein comprising lymphotoxin |
| 03/10/1992 | US5095095 Immunosuppressant factor protein capable of inhibiting T-cell mechanisms |
| 03/10/1992 | US5095094 A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity |
| 03/10/1992 | US5095093 Protective four amino acid epitope against Plasmodium vivax malaria |
| 03/10/1992 | US5095092 Process for the isolation and purification of hirudin |
| 03/10/1992 | US5095090 Protective coatings, electronics, biocompatability |
| 03/10/1992 | US5095006 Renin inhibitors having all retro-inverted peptide bonds |
| 03/10/1992 | US5095005 For foods |
| 03/10/1992 | US5095004 Fluorine containing atrial natriuretic peptides |
| 03/10/1992 | US5094951 Genetic engineering |
| 03/10/1992 | US5094949 Side effect reduction |
| 03/10/1992 | US5094941 Monoclonal antibodies to PDGF |
| 03/10/1992 | CA1297050C Expression systems for over production of desired proteins |
| 03/10/1992 | CA1297048C Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein |
| 03/10/1992 | CA1297011C Method of producing a factor viii (ahf) containing fraction |
| 03/10/1992 | CA1297005C Pharmaceutical agent for the treatment of myelogenous leukemia |
| 03/10/1992 | CA1297004C Pharmaceutical agent for promoting the recovery of hemopoietic capacity |
| 03/09/1992 | CA2050876A1 Recombinant expression vectors capable of expressing immunogenic malarial antigens on the surface of salmonella vaccine strains |
| 03/08/1992 | WO1992004371A1 Kininogenase inhibitors |
| 03/08/1992 | CA2090858A1 Kininogenase inhibitors |
| 03/08/1992 | CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process |
| 03/08/1992 | CA2050743A1 Expression of genes encoding plant pathogenesis related proteins in plant associated bacteria |
| 03/07/1992 | WO1992004049A1 Inhibitor of lymphocyte response and immune-related disease |
| 03/07/1992 | CA2071896A1 Inhibitor of lymphocyte response and immune-related disease |